GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abivax SA (NAS:ABVX) » Definitions » Other Gross PPE

ABVX (Abivax) Other Gross PPE : $0.56 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Abivax Other Gross PPE?

Abivax's Other Gross PPE for the quarter that ended in Dec. 2023 was $0.56 Mil.

Abivax's quarterly Other Gross PPE increased from Dec. 2022 ($0.39 Mil) to Jun. 2023 ($0.48 Mil) and increased from Jun. 2023 ($0.48 Mil) to Dec. 2023 ($0.56 Mil).

Abivax's annual Other Gross PPE declined from Dec. 2021 ($0.44 Mil) to Dec. 2022 ($0.39 Mil) but then increased from Dec. 2022 ($0.39 Mil) to Dec. 2023 ($0.56 Mil).

Abivax Other Gross PPE Historical Data

The historical data trend for Abivax's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abivax Other Gross PPE Chart

Abivax Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 - 0.44 0.39 0.56

Abivax Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 - 0.39 0.48 0.56

Abivax Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Abivax Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abivax SA (NAS:ABVX) » Definitions » Other Gross PPE
Comparable Companies
XPAR:MEDCL XPAR:VLA XPAR:ALSEN XPAR:GNFT XPAR:IPH XPAR:NANO XPAR:OSE XPAR:ALCLS XPAR:IVA XPAR:TNG VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
AAVXF:USA 0RA9:UK ABVX:France 2X1:Germany
Address
7-11 boulevard Haussmann, Paris, FRA, 75009
Website
https://www.abivax.com
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.